跳至主要内容
临床试验/CTRI/2021/08/035994
CTRI/2021/08/035994招募中不适用

Safety and efficacy of collagenase application in ocular burns: A prospective open- label academicrandomized controlled trial

Hyderabad Eye Research Foundation1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年8月31日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
1
主要终点
Proportion of cases showing complete restoration (epithelialization) of the ocular surface on clinical slit-lamp evaluation using fluorescein staining.

研究概览

简要总结

We propose to investigate the drug Collagenase in a prospective open-label randomized controlled academic clinical trial. In particular, we aim at evaluating the safety and efficacy of topical collagenase for the treatment of adult patients with acute severe unilateral chemical burns. This trial will be single centre, performed at the LV Prasad Eye Institute (LVPEI), in Hyderabad, India.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Patient should be 18 years and above of age.
  • 2.Patient should be able and prepared to complete all required clincial tests and examinations.
  • 3.Patient should be diagnosed with an acute (<14 days after injury) severe (grade II-IV) unilateral chemical burn.
  • 4.Patient should not have any other ocular abnormality in the injured eye.
  • 5.Able to provide informed consent prior to any study related procedures.

排除标准

  • Unwillingness to participate in the study.

结局指标

主要结局

Proportion of cases showing complete restoration (epithelialization) of the ocular surface on clinical slit-lamp evaluation using fluorescein staining.

时间窗: 28 days

次要结局

  • The proportion of patients showing 2-line improvement in BCVA from baseline will be computed along with 95% CIs.(The secondary end points will be at 3-months, 6-months and 1-year follow up visit.)

研究者

申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验